Range Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Range Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	7,942 -35	-0.4%	-$7.67K	0.52%	61
2026 Q1	$1.51M	Buy	7,977 +205	+3%	+$35.8K	0.51%	68
2025 Q4	$1.32M	Sell	7,772 -307	-4%	-$47.1K	0.46%	71
2025 Q3	$1.06M	Buy	8,079 +703	+10%	+$84.3K	0.38%	81
2025 Q2	$783K	Sell	7,376 -9	-0.1%	-$978	0.31%	99
2025 Q1	$917K	Buy	+7,385	New	+$963K	0.41%	79

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Range Financial Group's JAZZ Position: Q2 2026 in Review

Range Financial Group reduced its Jazz Pharmaceuticals (JAZZ) stake by 0.44% in Q2 2026, selling an estimated $7.67K and leaving 7,942 shares worth $1.91M. The position accounts for 0.52% of the portfolio, ranked #61.

Range Financial Group first reported a position in JAZZ in Q1 2025 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Range Financial Group held 7,942 shares of Jazz Pharmaceuticals worth $1.91M as of Q2 2026.
Range Financial Group sold 35 Jazz Pharmaceuticals shares in Q2 2026, an estimated $7.67K.
Jazz Pharmaceuticals made up 0.52% of Range Financial Group's portfolio in Q2 2026, its #61 holding.
Range Financial Group first reported a position in Jazz Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
69 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Range Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.